Welcome to our dedicated page for Baxter International news (Ticker: $BAX), a resource for investors and traders seeking the latest updates and insights on Baxter International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Baxter International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Baxter International's position in the market.
Baxter International Inc. (NYSE:BAX) will present at the Bank of America 2024 Health Care Conference with its chief financial officer, Joel Grade, scheduled to speak on May 15, 2024. The live webcast will be available for replay until August 14, 2024. Baxter is a global medtech leader offering a variety of healthcare products and solutions across the world.
Baxter International Inc. (NYSE:BAX) has declared a quarterly cash dividend of $0.29 per share of common stock, with an indicated annual dividend rate of $1.16 per share. The dividend will be payable on July 1, 2024, to stockholders of record as of May 31, 2024.
Baxter International Inc. reported first-quarter 2024 results with sales of $3.59 billion, up 2% on a reported basis and 3% on a constant currency basis, surpassing guidance. U.S. GAAP EPS was $0.07, adjusted EPS was $0.65. Full-year sales growth outlook is 2% (reported) and 2-3% (constant currency). Recent FDA clearance of Novum IQ large volume infusion pump and Dose IQ Safety Software. Baxter is focused on operational execution, innovation, and value creation for stakeholders.
